ストックスクリーナーアプリを入手
149.25
4.37%
6.25
前日終値:
$143.00
開ける：
$143.88
24時間の取引高:
1.00M
Relative Volume:
1.43
時価総額：
$8.02B
収益：
$1.97B
当期純損益:
$-494.50M
株価収益率:
-16.19
EPS:
-9.22
ネットキャッシュフロー:
$137.20M
1週間 パフォーマンス:
-1.24%
1か月 パフォーマンス:
+0.62%
6か月 パフォーマンス:
-0.09%
1年 パフォーマンス:
-11.75%
1日の値動き範囲:
$143.88
$150.84
1週間の範囲:
$139.76
$152.26
52週間の値動き範囲:
$133.70
$194.88
Masimo Corp Stock (MASI) Company Profile
MASI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
149.25 | 7.68B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-17 | 開始されました | BofA Securities | Neutral |
| 2024-12-27 | 繰り返されました | Raymond James | Outperform |
| 2024-11-06 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2024-06-03 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-04-15 | アップグレード | Stifel | Hold → Buy |
| 2024-03-25 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | ダウングレード | Jefferies | Buy → Hold |
| 2024-01-03 | ダウングレード | Needham | Buy → Hold |
| 2023-11-08 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-07-18 | ダウングレード | Stifel | Buy → Hold |
| 2023-07-10 | 開始されました | Wells Fargo | Equal Weight |
| 2023-02-22 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2022-12-15 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-12-05 | 繰り返されました | Needham | Buy |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-09-15 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2022-09-14 | 開始されました | Loop Capital | Buy |
| 2022-04-06 | 開始されました | Wolfe Research | Peer Perform |
| 2022-02-18 | アップグレード | Needham | Hold → Buy |
| 2022-02-16 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-10-12 | 再開されました | Raymond James | Mkt Perform |
| 2020-09-02 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-14 | 再開されました | Piper Sandler | Overweight |
| 2020-04-20 | ダウングレード | Needham | Buy → Hold |
| 2020-03-02 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2019-05-07 | 繰り返されました | Needham | Buy |
| 2019-04-16 | ダウングレード | BTIG Research | Buy → Neutral |
| 2019-03-13 | 繰り返されました | Needham | Buy |
| 2018-12-19 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2018-09-14 | 開始されました | Needham | Buy |
| 2018-03-09 | 開始されました | Barclays | Overweight |
| 2017-08-14 | アップグレード | BTIG Research | Neutral → Buy |
| 2017-04-04 | 繰り返されました | Wedbush | Outperform |
| 2017-03-16 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2017-02-27 | 繰り返されました | Wedbush | Outperform |
| 2017-02-13 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2016-08-04 | 繰り返されました | Wedbush | Outperform |
| 2016-05-05 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2016-05-05 | 繰り返されました | Wedbush | Outperform |
| 2016-01-06 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2015-08-05 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Masimo Corp (MASI) 最新ニュース
Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know - Finviz
Westfield Capital Management Co. LP Increases Stake in Masimo Corporation $MASI - MarketBeat
Masimo Corporation $MASI Shares Purchased by Geode Capital Management LLC - MarketBeat
SG Americas Securities LLC Grows Stock Holdings in Masimo Corporation $MASI - MarketBeat
Will Masimo Corporation (3M4) stock outperform global peersTrade Exit Summary & Reliable Price Breakout Alerts - newser.com
Is Masimo Corporation (3M4) stock a buy before new product rolloutWeekly Investment Report & Entry Point Strategy Guides - newser.com
How Masimo Corporation (3M4) stock reacts to Fed tightening2025 Momentum Check & Smart Swing Trading Techniques - newser.com
Verdict: Apple Hit With $634 Million in Damages in Masimo Lawsuit; Another Shoe May Drop - Strata-gee.com
Masimo Corporation stock volume spike explainedJuly 2025 Opening Moves & Fast Moving Trade Plans - newser.com
Analysts see tide turning toward Masimo in Apple patent war - BioWorld MedTech
Wall Street Analysts Believe Masimo (MASI) Could Rally 26.6%: Here's is How to Trade - Finviz
Masimo (NASDAQ:MASI) Earns Neutral Rating from Analysts at Bank of America - MarketBeat
Knobbe Martens Guides Masimo (NASDAQ: MASI) to $634M Jury Patent Win Over Apple - Stock Titan
Masimo Corp. Reports Strong Q3 2025 Growth - MSN
Masimo’s Twin Wins Over Apple Boost Leverage in Watch-Tech War - news.bloomberglaw.com
Bridger Management LLC Lowers Holdings in Masimo Corporation $MASI - MarketBeat
Apple Will Appeal $634M Jury Verdict in Patent Claim by Masimo Corp. - Law.com
BofA Securities initiates Masimo stock with Neutral rating, $162 price target By Investing.com - Investing.com South Africa
Apple’s $634 Million Watch Wound: Inside the Masimo Patent Verdict - WebProNews
Apple Watch faces ban after Masimo lawsuit loss — what you need to know - Yahoo
Masimo Wins $634M Verdict Against Apple - Orange County Business Journal
Masimo stock may rise after $634M patent verdict against Apple, Stifel says - Investing.com Nigeria
Masimo margin gains priced in while revenue growth stays slow, BofA rates Neutral - Investing.com Canada
BofA Securities initiates Masimo stock with Neutral rating, $162 price target - Investing.com Australia
Masimo Wins $634 Million in Apple Watch-Alerts Patent Trial (1) - news.bloomberglaw.com
Masimo Corporation $MASI Shares Purchased by Massachusetts Financial Services Co. MA - MarketBeat
Masimo (MASI): B of A Securities Initiates Coverage with Neutral Rating | MASI Stock News - GuruFocus
Federal judge says Apple owes medical tech company Masimo $634 million - MacTech.com
Masimo initiated with a Neutral at BofA on lack of imminent growth inflection - TipRanks
US jury says Apple must pay Masimo $634 million in smartwatch patent case - Reuters
Apple hit with $634M fine over Masimo patent dispute - Mobile World Live
OC500 2025: KATIE SZYMAN - Orange County Business Journal
Apple Ordered To Pay Over $600 Million In Smartwatch Patent Case Against MasimoMasimo (NASDAQ:MASI) - Benzinga
Predicting Masimo Corporation trend using moving averagesTrade Signal Summary & Daily Momentum Trading Reports - newser.com
4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares - sharewise.com
Apple Watch Faces $634M Legal Hit Over Blood-Oxygen Technology - parameter.io
Masimo (MASI) Secures $634 Million in Patent Infringement Case A - GuruFocus
Apple Watch ban: everything you need to know - The Verge
Masimo issues statement after court found Apple infringed on patent - TipRanks
Masimo (MASI) Is Up 5.6% After Winning $634 Million Verdict Against AppleHas The Bull Case Changed? - Yahoo Finance
Masimo Corporation $MASI Shares Sold by Calamos Advisors LLC - MarketBeat
U.S. jury says Apple must pay Masimo $634M in smartwatch patent case - Korea JoongAng Daily
Apple ordered to pay $634 million to Masimo in Apple Watch patent dispute - Times of India
Jury says Apple owes Masimo $634M for patent infringement - Yahoo Finance
Chart based analysis of Masimo Corporation trendsTrade Risk Assessment & Reliable Price Action Trade Plans - newser.com
Masimo (MASI) Wins $634M Patent Infringement Case Against Apple - GuruFocus
Apple Watch’s Blood Oxygen Saga: USITC Probes Redesigned Feature Amid Patent Clash - WebProNews
Apple Hit With $634M Verdict in High-Stakes Masimo Patent Showdown - USA Herald
Real time pattern detection on Masimo Corporation stockWeekly Trade Summary & Verified Momentum Watchlists - newser.com
Envestnet Asset Management Inc. Has $4.58 Million Holdings in Masimo Corporation $MASI - MarketBeat
Is Masimo Corporation stock a top momentum playGap Down & Stepwise Trade Signal Implementation - newser.com
Masimo Corp (MASI) 財務データ
収益
当期純利益
現金流量
EPS
5.84%
大文字化:
|
ボリューム (24 時間):